TOP TIERMARKET NEWSWIRE
SEC Form 4 history

PUMA BIOTECHNOLOGY I (PBYI) insider trades

PUMA BIOTECHNOLOGY I (PBYI) insider trading activity (SEC Form 4). Over the trailing 90 days, PBYI insiders filed 0 purchases totalling $0 and 8 sales totalling $1.1M — net SELLING of $1.1M. Most recent filing: Jul 8, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
8
$1.1M
Net (90d)
-$1.1M
net selling
Most recent
Jul 8, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 8, 2026Auerbach Alan HPres, CEO, 10%S Sale—$8.26$364Kfiling
Jul 8, 2026Hunt Douglas MSee RemarksS Sale—$8.26$70Kfiling
Jul 8, 2026Nougues Maximo FCFOS Sale—$8.26$78Kfiling
Jun 15, 2026Stuglik Brian MDirS Sale—$7.20$58Kfiling
Jun 15, 2026Wilson Troy EdwardDirS Sale—$7.20$78Kfiling
Jun 15, 2026Senderowicz AdrianDirS Sale—$7.20$194Kfiling
Jun 15, 2026Dorval AllisonDirS Sale—$7.20$84Kfiling
Jun 15, 2026Moyes Jay MDirS Sale—$7.22$159Kfiling